DK4092022T3 - Kristal af pde3/pde4-dualhæmmer og anvendelse deraf - Google Patents

Kristal af pde3/pde4-dualhæmmer og anvendelse deraf

Info

Publication number
DK4092022T3
DK4092022T3 DK21740747.7T DK21740747T DK4092022T3 DK 4092022 T3 DK4092022 T3 DK 4092022T3 DK 21740747 T DK21740747 T DK 21740747T DK 4092022 T3 DK4092022 T3 DK 4092022T3
Authority
DK
Denmark
Prior art keywords
pde3
dual inhibitor
inhibitor crystal
pde4
pde4 dual
Prior art date
Application number
DK21740747.7T
Other languages
English (en)
Inventor
Wenjun Yao
Yunfu Luo
Peng Zhang
Ting Yao
Original Assignee
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chia Tai Tianqing Pharmaceutical Group Co Ltd filed Critical Chia Tai Tianqing Pharmaceutical Group Co Ltd
Application granted granted Critical
Publication of DK4092022T3 publication Critical patent/DK4092022T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/02Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/04Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/28Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/29Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
    • C07C309/30Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings of six-membered aromatic rings substituted by alkyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13Dicarboxylic acids
    • C07C57/145Maleic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK21740747.7T 2020-01-15 2021-01-15 Kristal af pde3/pde4-dualhæmmer og anvendelse deraf DK4092022T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202010043882 2020-01-15
PCT/CN2021/072151 WO2021143843A1 (zh) 2020-01-15 2021-01-15 一种pde3/pde4双重抑制剂的结晶及其应用

Publications (1)

Publication Number Publication Date
DK4092022T3 true DK4092022T3 (da) 2025-12-01

Family

ID=76863637

Family Applications (1)

Application Number Title Priority Date Filing Date
DK21740747.7T DK4092022T3 (da) 2020-01-15 2021-01-15 Kristal af pde3/pde4-dualhæmmer og anvendelse deraf

Country Status (11)

Country Link
US (1) US20230115817A1 (da)
EP (2) EP4092022B1 (da)
JP (2) JP7648635B2 (da)
CN (2) CN114929701B (da)
AU (1) AU2021207159A1 (da)
CA (1) CA3167381A1 (da)
DK (1) DK4092022T3 (da)
ES (1) ES3053814T3 (da)
FI (1) FI4092022T3 (da)
PL (1) PL4092022T3 (da)
WO (1) WO2021143843A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7712276B2 (ja) * 2020-01-15 2025-07-23 チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッド 三環式pde3/pde4二重阻害剤化合物の医薬組成物
CA3167381A1 (en) * 2020-01-15 2021-07-22 Chia Tai Tianqing Pharmaceutical Group Co., Ltd Crystal of pde3/pde4 dual inhibitor and use thereof
TW202325301A (zh) 2021-12-14 2023-07-01 大陸商海思科醫藥集團股份有限公司 三環稠雜環類pde3/4雙重抑制及其用途
EP4467543A4 (en) * 2022-01-21 2025-12-17 Xizang Haisco Pharmaceutical Co Ltd TRICYCLICAL CONDENSED HETEROCYCLICAL PDE3/4 DOUBLE INTHIBITOR AND USE OF THEREBY
JP2026512778A (ja) * 2022-10-28 2026-04-21 江▲蘇▼恒瑞医▲薬▼股▲フン▼有限公司 イソキノリノン系化合物の結晶型及びその調製方法
WO2026012369A1 (zh) * 2024-07-09 2026-01-15 西藏海思科制药有限公司 一种pde3/4双重抑制剂的晶型物及其制备方法和应用
WO2026052051A1 (zh) * 2024-09-06 2026-03-12 正大天晴药业集团股份有限公司 杂环化合物在治疗肺疾病中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI64370C (fi) * 1977-05-05 1983-11-10 Hoechst Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara pyimido-(6,1-a)isokinolin-2-imino-4-onderivat
ZW6284A1 (en) * 1983-05-05 1985-10-30 Hoffmann La Roche Novel pyrimidone derivatives
EP1022868B1 (en) 1998-07-22 2004-11-24 Mitsubishi Denki Kabushiki Kaisha Mobile communication system and mobile communication method
DE60005493T2 (de) * 1999-03-31 2004-07-01 Vernalis Ltd., Wokingham Pyrimido[6,1-a]isochinolinonderivate
PT3822272T (pt) * 2018-07-13 2025-01-22 Chia Tai Tianqing Pharmaceutical Group Co Ltd Composto tricíclico fundido como inibidor duplo de pde3/pde4
JP7620938B2 (ja) * 2019-07-30 2025-01-24 ビクター チャン カーディアック リサーチ インスティテュート Klf誘導心筋再生
JP7712276B2 (ja) * 2020-01-15 2025-07-23 チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッド 三環式pde3/pde4二重阻害剤化合物の医薬組成物
CA3167381A1 (en) * 2020-01-15 2021-07-22 Chia Tai Tianqing Pharmaceutical Group Co., Ltd Crystal of pde3/pde4 dual inhibitor and use thereof
JP2024080444A (ja) * 2022-12-02 2024-06-13 オムロン株式会社 因子分析装置、方法、及びプログラム

Also Published As

Publication number Publication date
US20230115817A1 (en) 2023-04-13
CA3167381A1 (en) 2021-07-22
AU2021207159A1 (en) 2022-08-18
EP4092022B1 (en) 2025-10-29
FI4092022T3 (fi) 2025-12-03
EP4643947A3 (en) 2025-11-19
ES3053814T3 (en) 2026-01-26
CN119841824A (zh) 2025-04-18
JP2025090663A (ja) 2025-06-17
EP4643947A9 (en) 2026-02-18
EP4092022A1 (en) 2022-11-23
EP4643947A2 (en) 2025-11-05
FI4092022T9 (fi) 2026-02-09
EP4092022A4 (en) 2024-01-24
CN114929701B (zh) 2024-11-05
CN114929701A (zh) 2022-08-19
JP2023512471A (ja) 2023-03-27
JP7648635B2 (ja) 2025-03-18
WO2021143843A1 (zh) 2021-07-22
PL4092022T3 (pl) 2026-01-26

Similar Documents

Publication Publication Date Title
DK4092022T3 (da) Kristal af pde3/pde4-dualhæmmer og anvendelse deraf
DK3917616T3 (da) Heterocykliske forbindelser og anvendelse deraf
EP3925341A4 (en) CONFIGURATION AND SELECTION OF RESOURCES FOR CONNECTIONS BETWEEN DEVICES
EP3913001A4 (en) ANTI-CLD18A2 NANOBODY AND ITS USE
DK3454844T3 (da) Behandling af tyktarmskræft med en kombination af hdac-inhibitoren hbi-8000 og en pd-l1-inhibitor
DK3678668T3 (da) ENPP1-inhibitorer og deres anvendelse til behandling af kræft
DK3860990T3 (da) Inhibitorer for YAP/TAZ-TEAD interaktion og disses anvendelse ved behandlingen af cancer
EP4350671A4 (en) Foldable display device
DK4310087T3 (da) Brodannede tricykliske carbamoylpyridonforbindelser og anvendelse heraf
DK2015754T3 (da) Anvendelse af dpp-iv-inhibitorer
DK1931645T3 (da) N-(3-aminoquinoxalin-2-yl)-sulfonamidderivater og deres anvendelse som inhibitorer af phosphatidylinositol-3-kinase
DK2203440T3 (da) Inhibitorer af interaktionen mellem MDM2 og P53
DK4196479T5 (da) Substituerede pyridotriazinforbindelser og anvendelser deraf
DK1912636T3 (da) N-(arylamino)-sulfonamid-inhibitorer af mek
DK2687223T4 (da) Påvisning og behandling af demens
DE602006004463D1 (de) Kristallform von asenapinmaleat
DK3595665T3 (da) Dobbelthæmmere af magl og faah
DK3558314T3 (da) Rho kinase inhibitor BA-1049 (R) og aktive metabolitter deraf
DK3416945T3 (da) 6-aryl-4-(morpholin-4-yl)-1h-pyridin-2-on-forbindelser anvendelige ved behandlingen af cancer og diabetes
DK3892621T3 (da) Haloallylaminforbindelser og anvendelse deraf
DK1723135T5 (da) Ukendte hydroxy-6-heteroarylphenanthridiner og deres anvendelse som pde4-inhibitorer
EP3602856A4 (en) DISCOVERY AND REGISTRATION IN PASSIVE OPTICAL MULTI-CHANNEL NETWORKS (PON)
DK1778651T3 (da) Multivalente chelatorer til modificering og organisering af target-molekyler
DK3757295T3 (da) Container og brug af samme
DK1740601T3 (da) Myosin-letkæde-kinase-inhibitorer og deres anvendelse